CAS: 1513879-19-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | KDU691 REF: IN-DA01EO95CAS: 1513879-19-0 | % | 104.00 €~312.00 € | Tue 10 Dec 24 |
 | KDU691 REF: TM-T5421CAS: 1513879-19-0 | 98.68% | 57.00 €~389.00 € | Mon 16 Dec 24 |
 | KDU691 REF: 3D-NKC87919CAS: 1513879-19-0 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: IN-DA01EO95
| 10mg | 104.00 € | ||
| 25mg | 171.00 € | ||
| 50mg | 197.00 € | ||
| 100mg | 312.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
KDU691
CAS:1513879-19-0
KDU691 is a PI4K inhibitor.
Formula:
C22H18ClN5O2
Purity:
98.68%
Color and Shape:
Solid
Molecular weight:
419.86
Ref: TM-T5421
| 1mg | 57.00 € | ||
| 5mg | 117.00 € | ||
| 10mg | 157.00 € | ||
| 25mg | 230.00 € | ||
| 50mg | 299.00 € | ||
| 100mg | 389.00 € | ||
| 1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
KDU691
CAS:1513879-19-0
KDU691 is a drug target for the treatment of malariae and cancer. It is orally …
Formula:
C22H18ClN5O2
Purity:
Min. 95%
Molecular weight:
419.86 g/mol
Ref: 3D-NKC87919
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
